Whereas a physical interaction between CD44 and HYAL2 has been demonstrated in breast cancer cell line MDA-MB-231 and rat v-Src-transformed fibroblasts [50], [51], we were unable to demonstrate such an interaction in TIME cells using co-immunoprecipitation (data not shown). Here, HYAL2 is linked to breast carcinoma.